An experimental blood test was as accurate at detecting Alzheimer's disease in patients as much more costly and invasive procedures, according to a new JAMA study—findings that could soon make diagnosing the disease easier, more affordable, and more available.
Walgreens Boots Alliance says its CEO, Stefano Pessina, "has decided to step down as CEO" but "will assume the role" of executive chair of the company's board of directors, in today's bite-sized hospital and health industry news from the District of Columbia and Illinois.
While researchers for a while have been experimenting with how 3-D bioprinting could help address a variety of diseases, such as diabetes and cancer, they are now exploring how it could help treat Covid-19 as well—namely, through the printing of "miniature organs," Ellen Rosen reports for the New York Times.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.